Late toxicity and five year outcomes after high-dose-rate brachytherapy as a monotherapy for localized prostate cancer

BACKGROUND: To determine the 5-year outcome after high-dose-rate brachytherapy (HDR-BT) as a monotherapy. METHODS: Between 10/2003 and 06/2006, 36 patients with low (28) and intermediate (8) risk prostate cancer were treated by HDR-BT monotherapy. All patients received one implant and 4 fractions of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghadjar, Pirus, Oesch, Sebastian L, Rentsch, Cyrill A, Isaak, Bernhard, Cihoric, Nikola, Manser, Peter, Thalmann, George N, Aebersold, Daniel M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046044/
https://www.ncbi.nlm.nih.gov/pubmed/24885327
http://dx.doi.org/10.1186/1748-717X-9-122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046044/
https://www.ncbi.nlm.nih.gov/pubmed/24885327
http://dx.doi.org/10.1186/1748-717X-9-122

Ejemplares similares